Astria Therapeutics, Inc. Public Float
Astria Therapeutics, Inc. had Public Float of $370.23 million as of 2024-06-28, per its 10-K filed 2025-03-11.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-03-11
- 2024-06-28: Entity Public Float $370.23M.
- 2023-06-30: Entity Public Float $279.50M.
- 2022-06-30: Entity Public Float $25.56M.
- 2021-06-30: Entity Public Float $129.86M.
| Period end | Entity Public Float |
|---|---|
| 2024-06-28 | $370.23M 10-K · filed 2025-03-11 |
| 2023-06-30 | $279.50M 10-K · filed 2024-03-04 |
| 2022-06-30 | $25.56M 10-K · filed 2023-03-22 |
| 2021-06-30 | $129.86M 10-K · filed 2022-03-10 |
| 2020-06-30 | $101.27M 10-K/A · filed 2021-04-19 |
| 2019-06-30 | $73.36M 10-K · filed 2020-03-10 |
| 2018-06-30 | $63.32M 10-K · filed 2019-03-14 |
| 2017-06-30 | $24.63M 10-K · filed 2018-03-15 |
| 2016-06-30 | $22.13M 10-K · filed 2017-03-16 |
| 2015-06-30 | $69.10M 10-K · filed 2016-03-15 |